UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies

Therapeutic advances in neurological disorders, 2021-01, Vol.14, p.17562864211012835-17562864211012835

2021

Volltextzugriff (PDF)

Age-related blood transcriptional regulators affect disease progression in pediatric multiple sclerosis

Neurobiology of disease, 2023-01, Vol.176, p.105953-105953, Article 105953

2023

Volltextzugriff (PDF)

Deciphering the shift from benign to active relapsing-remitting multiple sclerosis: Insights into T regulatory cell dysfunction and apoptosis regulation

Neurobiology of disease, 2024-05, Vol.194, p.106475-106475, Article 106475

2024

Volltextzugriff (PDF)

Faster progression to multiple sclerosis disability is linked to neuronal pathways associated with neurodegeneration: An ethnicity study

PloS one, 2023-02, Vol.18 (2), p.e0280515-e0280515

2023

Volltextzugriff (PDF)

SARS‐CoV‐2 memory B and T cell profiles in mild COVID‐19 convalescent patients

International journal of infectious diseases, 2022-02, Vol.115, p.208-214

2022

Volltextzugriff (PDF)

Normalization of Large-Scale Transcriptome Data Using Heuristic Methods

Bioinformatics and biology insights, 2023-01, Vol.17, p.11779322231160397-11779322231160397

2023

Volltextzugriff (PDF)

The switch between relapse and remission in multiple sclerosis: Continuous inflammatory response balanced by Th1 suppression and neurotrophic factors

Journal of neuroimmunology, 2012-11, Vol.252 (1), p.83-88

2012

Volltextzugriff (PDF)

RAM-589.555 favors neuroprotective and anti-inflammatory profile of CNS-resident glial cells in acute relapse EAE affected mice

Journal of neuroinflammation, 2020-10, Vol.17 (1), p.1-313, Article 313

2020

Volltextzugriff (PDF)

No immediate change in systemic cytokines following an eccentric muscle training session in people with multiple sclerosis

Therapeutic advances in neurological disorders, 2024-01, Vol.17, p.17562864241266113

2024

Volltextzugriff (PDF)

Microarray analysis identifies altered regulation of nuclear receptor family members in the pre-disease state of multiple sclerosis

Neurobiology of disease, 2010-05, Vol.38 (2), p.201-209

2010

Volltextzugriff (PDF)

Potential role of indolelactate and butyrate in multiple sclerosis revealed by integrated microbiome-metabolome analysis

Cell reports. Medicine, 2021-04, Vol.2 (4), p.100246-100246, Article 100246

2021

Volltextzugriff (PDF)

Generation of vascular chimerism within donor organs

Scientific reports, 2021-06, Vol.11 (1), p.13437-13437, Article 13437

2021

Volltextzugriff (PDF)

Suppressed RNA-polymerase 1 pathway is associated with benign multiple sclerosis

PloS one, 2012-10, Vol.7 (10), p.e46871-e46871

2012

Volltextzugriff (PDF)

Kidney Transplantation during the SARS-CoV-2 Pandemic in Israel: Experience from a Large-Volume Center

Transplantology (Basel, Switzerland), 2021-12, Vol.2 (4), p.433-440

2021

Volltextzugriff (PDF)

Author response to: Correspondence to humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies

Therapeutic advances in neurological disorders, 2021, Vol.14, p.175628642110200-17562864211020082

2021

Volltextzugriff (PDF)

The role of the vasculature niche on insulin-producing cells generated by transdifferentiation of adult human liver cells

Stem cell research & therapy, 2019-02, Vol.10 (1), p.53-53, Article 53

2019

Volltextzugriff (PDF)

Resolving bulimia nervosa using an innovative neural therapy approach: two case reports

Clinical case reports, 2018-02, Vol.6 (2), p.278-282

2018

Volltextzugriff (PDF)

Prediction of acute multiple sclerosis relapses by transcription levels of peripheral blood cells

BMC medical genomics, 2009-07, Vol.2 (1), p.46-46, Article 46

2009

Volltextzugriff (PDF)

Characterization of the multiple sclerosis traits: Nuclear receptors (NR) impaired apoptosis pathway and the role of 1-alpha 25-dihydroxyvitamin D3

Journal of the neurological sciences, 2011-12, Vol.311 (1), p.9-14

2011

Volltextzugriff (PDF)

Diversity in NIME Research Practices

Leonardo (Oxford), 2016-02, Vol.49 (1), p.80-81

Gurevich, Michael

2016

Volltextzugriff (PDF)

Molecular profiling of glatiramer acetate early treatment effects in multiple sclerosis

Disease markers, 2009, Vol.27 (2), p.63-73

2009

Volltextzugriff (PDF)

Humoral immune response in multiple sclerosis patients following PfizerBNT162b2 COVID19 vaccination: Up to 6 months cross-sectional study

Journal of neuroimmunology, 2021-12, Vol.361, p.577746-577746, Article 577746

2021

Volltextzugriff (PDF)

COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021

Multiple sclerosis, 2021-05, Vol.27 (6), p.864-870

2021

Volltextzugriff (PDF)

Molecular profiling of glatiramer acetate early treatment effects in multiple sclerosis

Disease markers, 2009-01, Vol.27 (2), p.63-73

2009

Volltextzugriff (PDF)

Heuristic normalization procedure for batch effect correction

Soft computing (Berlin, Germany), 2023-06, Vol.27 (12), p.7813-7829

2023

Volltextzugriff (PDF)

1 – 25 von 179

Suche als RSS-Feed

Aktive Filter

KollektionJournals@Ovid Ovid Full Text

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(142)
Mit Volltextzugriff
(153)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(178)
Hebräisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies

Age-related blood transcriptional regulators affect disease progression in pediatric multiple sclerosis

Deciphering the shift from benign to active relapsing-remitting multiple sclerosis: Insights into T regulatory cell dysfunction and apoptosis regulation

Faster progression to multiple sclerosis disability is linked to neuronal pathways associated with neurodegeneration: An ethnicity study

SARS‐CoV‐2 memory B and T cell profiles in mild COVID‐19 convalescent patients

Normalization of Large-Scale Transcriptome Data Using Heuristic Methods

The switch between relapse and remission in multiple sclerosis: Continuous inflammatory response balanced by Th1 suppression and neurotrophic factors

RAM-589.555 favors neuroprotective and anti-inflammatory profile of CNS-resident glial cells in acute relapse EAE affected mice

No immediate change in systemic cytokines following an eccentric muscle training session in people with multiple sclerosis

Microarray analysis identifies altered regulation of nuclear receptor family members in the pre-disease state of multiple sclerosis

Potential role of indolelactate and butyrate in multiple sclerosis revealed by integrated microbiome-metabolome analysis

Generation of vascular chimerism within donor organs

Suppressed RNA-polymerase 1 pathway is associated with benign multiple sclerosis

Kidney Transplantation during the SARS-CoV-2 Pandemic in Israel: Experience from a Large-Volume Center

Author response to: Correspondence to humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies

The role of the vasculature niche on insulin-producing cells generated by transdifferentiation of adult human liver cells

Resolving bulimia nervosa using an innovative neural therapy approach: two case reports

Prediction of acute multiple sclerosis relapses by transcription levels of peripheral blood cells

Characterization of the multiple sclerosis traits: Nuclear receptors (NR) impaired apoptosis pathway and the role of 1-alpha 25-dihydroxyvitamin D3

Diversity in NIME Research Practices

Molecular profiling of glatiramer acetate early treatment effects in multiple sclerosis

Humoral immune response in multiple sclerosis patients following PfizerBNT162b2 COVID19 vaccination: Up to 6 months cross-sectional study

COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021

Molecular profiling of glatiramer acetate early treatment effects in multiple sclerosis

Heuristic normalization procedure for batch effect correction

Aktive Filter

Suchergebnisse filtern